About
Device to prevent digestion and promote weight loss
Areas of Focus
Categories
Medical ImplantBoston & New England
Clinical Trials (17)
View allTotal Trials
17
As Lead Sponsor
16
As Collaborator
1
Total Enrollment
2,299
By Phase
NA: 8PHASE2: 5PHASE1/PHASE2: 1
By Status
COMPLETED: 10TERMINATED: 3UNKNOWN: 2RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT04101669Lead Sponsor
RESET System Pivotal Trial (Rev F)
NARecruiting
264 participants
Started: Sep 9, 2019 · Completed: Dec 1, 2026
NCT02443753Lead Sponsor
EndoBarrier® SANS™ in Over-weight or Obese Type 2 Diabetic Subjects
NATerminated
7 participants
Started: May 31, 2015 · Completed: Jul 31, 2015
NCT02293720Lead Sponsor
An Open-Label Extension to Protocol 09-1, Efficacy and Safety Study of the EndoBarrier® Gastrointestinal Liner System
NAWithdrawn
Started: Apr 30, 2015 · Completed: Jul 31, 2016
NCT02146118Lead Sponsor
A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma
PHASE2Unknown
42 participants
Started: Apr 30, 2014 · Completed: Mar 31, 2016
NCT02731859Collaborator
EndoBarrier Register Deutschland-Safety and Efficacy of the Endoscopic Duodenal-Jejunal Bypass Sleeve
N/AUnknown
1,000 participants
Started: Jan 31, 2014 · Completed: Jan 31, 2019
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...